Annual report
2927.TEDINET S100UT2C
Period2023-09-01 → 2024-08-31
Filed2024-11-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 156
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥30.2bn | 2023-09-01 → 2024-08-31 | Cons. | Net sales |
| Revenue | ¥25.6bn | 2022-09-01 → 2023-08-31 | Cons. | Net sales |
| Revenue | ¥23.0bn | 2021-09-01 → 2022-08-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥22.4bn | 2020-09-01 → 2021-08-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥15.8bn | 2019-09-01 → 2020-08-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.9bn | 2023-09-01 → 2024-08-31 | Cons. | Operating income |
| Operating income | ¥1.6bn | 2022-09-01 → 2023-08-31 | Cons. | Operating income |
| Ordinary income | ¥1.9bn | 2023-09-01 → 2024-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.7bn | 2022-09-01 → 2023-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2021-09-01 → 2022-08-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.2bn | 2020-09-01 → 2021-08-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2019-09-01 → 2020-08-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.9bn | 2023-09-01 → 2024-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.5bn | 2022-09-01 → 2023-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.3bn | 2023-09-01 → 2024-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.1bn | 2022-09-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥735m | 2021-09-01 → 2022-08-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.5bn | 2020-09-01 → 2021-08-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥677m | 2019-09-01 → 2020-08-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.2bn | 2023-09-01 → 2024-08-31 | Cons. | Profit loss |
| Net income | ¥1.1bn | 2022-09-01 → 2023-08-31 | Cons. | Profit loss |
| Total assets | ¥47.0bn | at 2024-08-31 | Cons. | Assets |
| Total assets | ¥41.1bn | at 2023-08-31 | Cons. | Assets |
| Total assets | ¥37.3bn | at 2022-08-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥35.8bn | at 2021-08-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥18.5bn | at 2020-08-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥33.1bn | at 2024-08-31 | Cons. | Liabilities |
| Total liabilities | ¥27.9bn | at 2023-08-31 | Cons. | Liabilities |
| Net assets / equity | ¥14.0bn | at 2024-08-31 | Cons. | Net assets |
| Net assets / equity | ¥13.2bn | at 2023-08-31 | Cons. | Net assets |
| Net assets / equity | ¥12.4bn | at 2022-08-31d | Cons. | Net assets |
| Net assets / equity | ¥12.7bn | at 2021-08-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥10.5bn | at 2020-08-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥12.2bn | at 2024-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥11.2bn | at 2023-08-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥12.1bn | at 2024-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.1bn | at 2023-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.3bn | at 2022-08-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.7bn | at 2021-08-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥4.2bn | at 2020-08-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.5bn | 2023-09-01 → 2024-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥865m | 2022-09-01 → 2023-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.5bn | 2021-09-01 → 2022-08-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.6bn | 2020-09-01 → 2021-08-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.3bn | 2019-09-01 → 2020-08-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.8bn | 2023-09-01 → 2024-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.9bn | 2022-09-01 → 2023-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2021-09-01 → 2022-08-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥275m | 2020-09-01 → 2021-08-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥459m | 2019-09-01 → 2020-08-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥2.2bn | 2023-09-01 → 2024-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.9bn | 2022-09-01 → 2023-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.2bn | 2021-09-01 → 2022-08-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.2bn | 2020-09-01 → 2021-08-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥575m | 2019-09-01 → 2020-08-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥89.2 | 2023-09-01 → 2024-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥78.51 | 2022-09-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.33 | 2021-09-01 → 2022-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥107.12 | 2020-09-01 → 2021-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.12 | 2019-09-01 → 2020-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥89.11 | 2023-09-01 → 2024-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥78.46 | 2022-09-01 → 2023-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥52.08 | 2021-09-01 → 2022-08-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥106.3 | 2020-09-01 → 2021-08-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥990.1 | at 2024-08-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥938.25 | at 2023-08-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥884.53 | at 2022-08-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥833.44 | at 2021-08-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥744.04 | at 2020-08-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 29.6% | at 2024-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.9% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.2% | at 2022-08-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2021-08-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.4% | at 2020-08-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 9.3% | 2023-09-01 → 2024-08-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.6% | 2022-09-01 → 2023-08-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.1% | 2021-09-01 → 2022-08-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.4% | 2020-09-01 → 2021-08-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.6% | 2019-09-01 → 2020-08-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 994 | at 2024-08-31 | Cons. | Number of employees |
| Employees | 878 | at 2023-08-31 | Cons. | Number of employees |
| Employees | 799 | at 2022-08-31d | Cons. | Number of employees |
| Employees | 793 | at 2021-08-31d | Cons. | Number of employees |
| Employees | 592 | at 2020-08-31d | Cons. | Number of employees |
| Revenue | ¥14.1bn | 2023-09-01 → 2024-08-31 | Standalone | Net sales |
| Revenue | ¥11.9bn | 2022-09-01 → 2023-08-31 | Standalone | Net sales |
| Revenue | ¥11.6bn | 2021-09-01 → 2022-08-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥14.4bn | 2020-09-01 → 2021-08-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥13.1bn | 2019-09-01 → 2020-08-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.2bn | 2023-09-01 → 2024-08-31 | Standalone | Operating income |
| Operating income | ¥1.1bn | 2022-09-01 → 2023-08-31 | Standalone | Operating income |
| Ordinary income | ¥1.4bn | 2023-09-01 → 2024-08-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.3bn | 2022-09-01 → 2023-08-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.0bn | 2021-09-01 → 2022-08-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2020-09-01 → 2021-08-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥851m | 2019-09-01 → 2020-08-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.3bn | 2023-09-01 → 2024-08-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.2bn | 2022-09-01 → 2023-08-31 | Standalone | Income before income taxes |
| Net income | ¥969m | 2023-09-01 → 2024-08-31 | Standalone | Profit loss |
| Net income | ¥954m | 2022-09-01 → 2023-08-31 | Standalone | Profit loss |
| Net income | ¥724m | 2021-09-01 → 2022-08-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥868m | 2020-09-01 → 2021-08-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥549m | 2019-09-01 → 2020-08-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥31.5bn | at 2024-08-31 | Standalone | Assets |
| Total assets | ¥29.2bn | at 2023-08-31 | Standalone | Assets |
| Total assets | ¥27.6bn | at 2022-08-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥26.5bn | at 2021-08-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥15.3bn | at 2020-08-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥20.2bn | at 2024-08-31 | Standalone | Liabilities |
| Total liabilities | ¥18.5bn | at 2023-08-31 | Standalone | Liabilities |
| Net assets / equity | ¥11.3bn | at 2024-08-31 | Standalone | Net assets |
| Net assets / equity | ¥10.7bn | at 2023-08-31 | Standalone | Net assets |
| Net assets / equity | ¥10.2bn | at 2022-08-31d | Standalone | Net assets |
| Net assets / equity | ¥10.1bn | at 2021-08-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥9.3bn | at 2020-08-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥5.2bn | at 2024-08-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥5.5bn | at 2023-08-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥69.06 | 2023-09-01 → 2024-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.93 | 2022-09-01 → 2023-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥51.55 | 2021-09-01 → 2022-08-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥62.15 | 2020-09-01 → 2021-08-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.03 | 2019-09-01 → 2020-08-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥68.99 | 2023-09-01 → 2024-08-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥67.88 | 2022-09-01 → 2023-08-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥51.31 | 2021-09-01 → 2022-08-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥61.67 | 2020-09-01 → 2021-08-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥30 | 2023-09-01 → 2024-08-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥27.5 | 2022-09-01 → 2023-08-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2021-09-01 → 2022-08-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥27.5 | 2020-09-01 → 2021-08-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2019-09-01 → 2020-08-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥800.93 | at 2024-08-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥764.17 | at 2023-08-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥722.39 | at 2022-08-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥705.25 | at 2021-08-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥659.44 | at 2020-08-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 35.8% | at 2024-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.6% | at 2023-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.7% | at 2022-08-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.7% | at 2021-08-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.6% | at 2020-08-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 8.8% | 2023-09-01 → 2024-08-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.2% | 2022-09-01 → 2023-08-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2021-09-01 → 2022-08-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.0% | 2020-09-01 → 2021-08-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2019-09-01 → 2020-08-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 14,387,699 | at 2024-08-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 14,387,699 | at 2023-08-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 14,387,699 | at 2022-08-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 14,387,699 | at 2021-08-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 14,144,720 | at 2020-08-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 363 | at 2024-08-31 | Standalone | Number of employees |
| Employees | 330 | at 2023-08-31 | Standalone | Number of employees |
| Employees | 325 | at 2022-08-31d | Standalone | Number of employees |
| Employees | 324 | at 2021-08-31d | Standalone | Number of employees |
| Employees | 346 | at 2020-08-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 106
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | capex | 2023-09-01 → 2024-08-31 | ¥4m |
| Otherother segments | depreciation | 2023-09-01 → 2024-08-31 | ¥27m |
| Otherother segments | employees | at 2024-08-31 | 155 pure |
| Otherother segments | revenue | 2023-09-01 → 2024-08-31 | ¥772m |
| Otherother segments | revenue external | 2023-09-01 → 2024-08-31 | ¥758m |
| Otherother segments | revenue intersegment | 2023-09-01 → 2024-08-31 | ¥15m |
| Otherother segments | segment assets | at 2024-08-31 | ¥1.8bn |
| Otherother segments | segment profit | 2023-09-01 → 2024-08-31 | −¥98m |
| Reconciling Itemsreconciling | capex | 2023-09-01 → 2024-08-31 | ¥511m |
| Reconciling Itemsreconciling | depreciation | 2023-09-01 → 2024-08-31 | ¥6m |
| Reconciling Itemsreconciling | revenue | 2023-09-01 → 2024-08-31 | −¥178m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-09-01 → 2024-08-31 | −¥178m |
| Reconciling Itemsreconciling | segment assets | at 2024-08-31 | ¥1.8bn |
| Reconciling Itemsreconciling | segment profit | 2023-09-01 → 2024-08-31 | −¥608m |
| Department Store Businessreportable segment | capex | 2023-09-01 → 2024-08-31 | ¥305m |
| Department Store Businessreportable segment | depreciation | 2023-09-01 → 2024-08-31 | ¥319m |
| Department Store Businessreportable segment | employees | at 2024-08-31 | 139 pure |
| Department Store Businessreportable segment | revenue | 2023-09-01 → 2024-08-31 | ¥5.0bn |
| Department Store Businessreportable segment | revenue external | 2023-09-01 → 2024-08-31 | ¥4.9bn |
| Department Store Businessreportable segment | revenue intersegment | 2023-09-01 → 2024-08-31 | ¥4m |
| Department Store Businessreportable segment | segment assets | at 2024-08-31 | ¥12.0bn |
| Department Store Businessreportable segment | segment profit | 2023-09-01 → 2024-08-31 | ¥33m |
| Food Service Businessreportable segment | capex | 2023-09-01 → 2024-08-31 | ¥241m |
| Food Service Businessreportable segment | depreciation | 2023-09-01 → 2024-08-31 | ¥61m |
| Food Service Businessreportable segment | employees | at 2024-08-31 | 112 pure |
| Food Service Businessreportable segment | revenue | 2023-09-01 → 2024-08-31 | ¥2.2bn |
| Food Service Businessreportable segment | revenue external | 2023-09-01 → 2024-08-31 | ¥2.2bn |
| Food Service Businessreportable segment | revenue intersegment | 2023-09-01 → 2024-08-31 | ¥13m |
| Food Service Businessreportable segment | segment assets | at 2024-08-31 | ¥2.9bn |
| Food Service Businessreportable segment | segment profit | 2023-09-01 → 2024-08-31 | −¥71m |
| Health Carereportable segment | capex | 2023-09-01 → 2024-08-31 | ¥336m |
| Health Carereportable segment | depreciation | 2023-09-01 → 2024-08-31 | ¥304m |
| Health Carereportable segment | employees | at 2024-08-31 | 509 pure |
| Health Carereportable segment | revenue | 2023-09-01 → 2024-08-31 | ¥18.2bn |
| Health Carereportable segment | revenue external | 2023-09-01 → 2024-08-31 | ¥18.1bn |
| Health Carereportable segment | revenue intersegment | 2023-09-01 → 2024-08-31 | ¥101m |
| Health Carereportable segment | segment assets | at 2024-08-31 | ¥20.0bn |
| Health Carereportable segment | segment profit | 2023-09-01 → 2024-08-31 | ¥2.7bn |
| Medical Productsreportable segment | capex | 2023-09-01 → 2024-08-31 | ¥152m |
| Medical Productsreportable segment | depreciation | 2023-09-01 → 2024-08-31 | ¥78m |
| Medical Productsreportable segment | employees | at 2024-08-31 | 61 pure |
| Medical Productsreportable segment | revenue | 2023-09-01 → 2024-08-31 | ¥2.3bn |
| Medical Productsreportable segment | revenue external | 2023-09-01 → 2024-08-31 | ¥2.3bn |
| Medical Productsreportable segment | segment assets | at 2024-08-31 | ¥1.8bn |
| Medical Productsreportable segment | segment profit | 2023-09-01 → 2024-08-31 | ¥216m |
| Real Estate And Consignment Businessreportable segment | capex | 2023-09-01 → 2024-08-31 | ¥1.4bn |
| Real Estate And Consignment Businessreportable segment | depreciation | 2023-09-01 → 2024-08-31 | ¥67m |
| Real Estate And Consignment Businessreportable segment | revenue | 2023-09-01 → 2024-08-31 | ¥2.0bn |
| Real Estate And Consignment Businessreportable segment | revenue external | 2023-09-01 → 2024-08-31 | ¥1.9bn |
| Real Estate And Consignment Businessreportable segment | revenue intersegment | 2023-09-01 → 2024-08-31 | ¥44m |
| Real Estate And Consignment Businessreportable segment | segment assets | at 2024-08-31 | ¥6.6bn |
| Real Estate And Consignment Businessreportable segment | segment profit | 2023-09-01 → 2024-08-31 | −¥268m |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-09-01 → 2024-08-31 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-09-01 → 2024-08-31 | ¥857m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-09-01 → 2024-08-31 | ¥30.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-09-01 → 2024-08-31 | ¥30.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-09-01 → 2024-08-31 | ¥178m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-08-31 | ¥45.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-09-01 → 2024-08-31 | ¥2.5bn |
| Otherother segments | capex | 2022-09-01 → 2023-08-31 | ¥59m |
| Otherother segments | depreciation | 2022-09-01 → 2023-08-31 | ¥36m |
| Otherother segments | revenue | 2022-09-01 → 2023-08-31 | ¥258m |
| Otherother segments | revenue external | 2022-09-01 → 2023-08-31 | ¥258m |
| Otherother segments | segment assets | at 2023-08-31 | ¥1.3bn |
| Otherother segments | segment profit | 2022-09-01 → 2023-08-31 | −¥83m |
| Reconciling Itemsreconciling | capex | 2022-09-01 → 2023-08-31 | ¥31m |
| Reconciling Itemsreconciling | depreciation | 2022-09-01 → 2023-08-31 | ¥9m |
| Reconciling Itemsreconciling | segment assets | at 2023-08-31 | ¥1.4bn |
| Reconciling Itemsreconciling | segment profit | 2022-09-01 → 2023-08-31 | −¥515m |
| Department Store Businessreportable segment | capex | 2022-09-01 → 2023-08-31 | ¥73m |
| Department Store Businessreportable segment | depreciation | 2022-09-01 → 2023-08-31 | ¥329m |
| Department Store Businessreportable segment | revenue | 2022-09-01 → 2023-08-31 | ¥5.2bn |
| Department Store Businessreportable segment | revenue external | 2022-09-01 → 2023-08-31 | ¥5.2bn |
| Department Store Businessreportable segment | segment assets | at 2023-08-31 | ¥12.4bn |
| Department Store Businessreportable segment | segment profit | 2022-09-01 → 2023-08-31 | ¥95m |
| Food Service Businessreportable segment | capex | 2022-09-01 → 2023-08-31 | ¥49m |
| Food Service Businessreportable segment | depreciation | 2022-09-01 → 2023-08-31 | ¥34m |
| Food Service Businessreportable segment | revenue | 2022-09-01 → 2023-08-31 | ¥1.5bn |
| Food Service Businessreportable segment | revenue external | 2022-09-01 → 2023-08-31 | ¥1.5bn |
| Food Service Businessreportable segment | segment assets | at 2023-08-31 | ¥2.3bn |
| Food Service Businessreportable segment | segment profit | 2022-09-01 → 2023-08-31 | −¥119m |
| Health Carereportable segment | capex | 2022-09-01 → 2023-08-31 | ¥916m |
| Health Carereportable segment | depreciation | 2022-09-01 → 2023-08-31 | ¥318m |
| Health Carereportable segment | revenue | 2022-09-01 → 2023-08-31 | ¥15.2bn |
| Health Carereportable segment | revenue external | 2022-09-01 → 2023-08-31 | ¥15.2bn |
| Health Carereportable segment | segment assets | at 2023-08-31 | ¥19.8bn |
| Health Carereportable segment | segment profit | 2022-09-01 → 2023-08-31 | ¥2.0bn |
| Medical Productsreportable segment | capex | 2022-09-01 → 2023-08-31 | ¥68m |
| Medical Productsreportable segment | depreciation | 2022-09-01 → 2023-08-31 | ¥85m |
| Medical Productsreportable segment | revenue | 2022-09-01 → 2023-08-31 | ¥2.1bn |
| Medical Productsreportable segment | revenue external | 2022-09-01 → 2023-08-31 | ¥2.1bn |
| Medical Productsreportable segment | segment assets | at 2023-08-31 | ¥1.7bn |
| Medical Productsreportable segment | segment profit | 2022-09-01 → 2023-08-31 | ¥202m |
| Real Estate And Consignment Businessreportable segment | capex | 2022-09-01 → 2023-08-31 | ¥822m |
| Real Estate And Consignment Businessreportable segment | depreciation | 2022-09-01 → 2023-08-31 | ¥13m |
| Real Estate And Consignment Businessreportable segment | revenue | 2022-09-01 → 2023-08-31 | ¥1.3bn |
| Real Estate And Consignment Businessreportable segment | revenue external | 2022-09-01 → 2023-08-31 | ¥1.3bn |
| Real Estate And Consignment Businessreportable segment | segment assets | at 2023-08-31 | ¥2.3bn |
| Real Estate And Consignment Businessreportable segment | segment profit | 2022-09-01 → 2023-08-31 | ¥65m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-09-01 → 2023-08-31 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-09-01 → 2023-08-31 | ¥815m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-09-01 → 2023-08-31 | ¥25.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-09-01 → 2023-08-31 | ¥25.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-08-31 | ¥39.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-09-01 → 2023-08-31 | ¥2.2bn |
| Health Carereportable segment | employees | at 2024-08-31 | 345 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,745
| Item | Context | Value | Unit |
|---|---|---|---|
| Research and development expenses sga | Prior1YearDuration | 145058000 | JPY |
| Research and development expenses sga | CurrentYearDuration | 148207000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E01064-000HealthCareReportableSegmentsMember | 15249817000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E01064-000MedicalProductsReportableSegmentsMember | 2087128000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E01064-000DepartmentStoreBusinessReportableSegmentMember | 5203982000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E01064-000FoodServiceBusinessReportableSegmentMember | 1482588000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E01064-000RealEstateAndConsignmentBusinessReportableSegmentMember | 1297440000 | JPY |
| Revenues from external customers | Prior1YearDuration_OtherReportableSegmentsMember | 258051000 | JPY |
| Revenues from external customers | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 25579009000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YearDuration | 25579009000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E01064-000HealthCareReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E01064-000MedicalProductsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E01064-000DepartmentStoreBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E01064-000FoodServiceBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E01064-000RealEstateAndConsignmentBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_OtherReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration | － | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E01064-000HealthCareReportableSegmentsMember | 15249817000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E01064-000MedicalProductsReportableSegmentsMember | 2087128000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E01064-000DepartmentStoreBusinessReportableSegmentMember | 5203982000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E01064-000FoodServiceBusinessReportableSegmentMember | 1482588000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E01064-000RealEstateAndConsignmentBusinessReportableSegmentMember | 1297440000 | JPY |
| Net sales | Prior1YearDuration_OtherReportableSegmentsMember | 258051000 | JPY |
| Net sales | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 25579009000 | JPY |
| Net sales | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YearDuration | 25579009000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E01064-000HealthCareReportableSegmentsMember | 1991977000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E01064-000MedicalProductsReportableSegmentsMember | 202207000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E01064-000DepartmentStoreBusinessReportableSegmentMember | 94647000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E01064-000FoodServiceBusinessReportableSegmentMember | -119366000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E01064-000RealEstateAndConsignmentBusinessReportableSegmentMember | 64800000 | JPY |
| Operating income | Prior1YearDuration_OtherReportableSegmentsMember | -83300000 | JPY |
| Operating income | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 2150966000 | JPY |
| Operating income | Prior1YearDuration_ReconcilingItemsMember | -514681000 | JPY |
| Operating income | Prior1YearDuration | 1636285000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E01064-000HealthCareReportableSegmentsMember | 19824250000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E01064-000MedicalProductsReportableSegmentsMember | 1674191000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E01064-000DepartmentStoreBusinessReportableSegmentMember | 12394509000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E01064-000FoodServiceBusinessReportableSegmentMember | 2270744000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E01064-000RealEstateAndConsignmentBusinessReportableSegmentMember | 2277414000 | JPY |
| Assets | Prior1YearInstant_OtherReportableSegmentsMember | 1280044000 | JPY |
| Assets | Prior1YearInstant_TotalOfReportableSegmentsAndOthersMember | 39721155000 | JPY |
| Assets | Prior1YearInstant_ReconcilingItemsMember | 1350593000 | JPY |
| Assets | Prior1YearInstant | 41071748000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E01064-000HealthCareReportableSegmentsMember | 318100000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E01064-000MedicalProductsReportableSegmentsMember | 84526000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E01064-000DepartmentStoreBusinessReportableSegmentMember | 328574000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |